Skip to content
Aperlena

Germany - Pharmaceuticals - Discount agreements under § 130a para. 8 SGB V in open-house procedures

Original Deutschland - Arzneimittel - Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

Open Contract notice

Key facts

Closes in
585 days
Buyer
IKK classic
Where
Germany Dresden
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
German
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
426545-2026
Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

  1. Published
  2. Today
  3. Deadline open for 683 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 17 different companies have won the last 18 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Expected final price vs the published estimate
0%

Based on 18 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

IKK classic, a German statutory health insurer, intends to conclude non-exclusive rebate agreements for various active substances and combinations under § 130a para. 8 SGB V with all interested and suitable pharmaceutical companies, using an open-house procedure with uniform, non-negotiable terms. The contract period runs from 01.07.2026 to 30.06.2028. The earliest possible start is 01.07.2026 if signed contracts and all required documents, declarations and proof are received by 05.06.2026. After that, documents received by the 5th of a month lead to a contract start on the 1st of the following month; later receipt means the 1st of the second following month. Joining is possible at any time until 05.05.2028. Any suitable pharmaceutical company may participate.

Description

Die IKK classic gibt hiermit bekannt, dass sie mit allen interessierten und geeigneten pharmazeutischen Unternehmen im Zeitraum vom 01.07.2026 bis zum 30.06.2028 zu verschiedenen Wirkstoffen und Wirkstoffkombinationen nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu gleichen, nicht verhandelbaren Bedingungen abschließen wird. Frühester Vertragsbeginn ist der 01.07.2026, sofern der unterschriebene Vertrag und alle nötigen Nachweise, Eigenerklärungen und Unterlagen bis zum 05.06.2026 bei der IKK classic eingehen. Danach gilt: Bei Eingang der Unterlagen bis zum 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des Folgemonats Vertragsbeginn. Bei Eingang der Unterlagen nach dem 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des übernächsten Folgemonats Vertragsbeginn. Ein Beitritt zur Vereinbarung ist im angegebenen Zeitraum jederzeit möglich, spätestens jedoch bis zum 05.05.2028. Weitere Angaben siehe Pkt. VI.3). Adalimumab; ohne 80 mg; ATC-Code: L04AB04; Adapalen 3 mg/g und Benzoylperoxid 25 mg/g ; ATC-Code: D10AD23 (ADV), D10AD53 (WHO); Aflibercept; 40 mg/ml; ATC-Code: S01LA05; Alglucosidase alfa; ATC-Code: A16AB07; Bimatoprost; Wirkstärke 0,1 mg/ml; ATC-Code: S01EE03; Biperiden; ATC-Code: N04AA02; Brolucizumab; ATC-Code: S01LA06; Budesonid; Magensaftresistente Hartkapseln; ATC-Code: A07EA06; Dabrafenib; ATC-Code: L01EC02; Dalteparin; ATC-Code: B01AB04; Diazepam; ATC-Code: N05BA01; Dimethylfumarat - zur Behandlung der schubförmig remittierenden MS; Wirkstärke 120 mg, Packungsgröße 28 HKM und 56 HKM (N2); Wirkstärke 240 mg, Packungsgröße 196 HKM (N3); ATC-Code: L04AX07; Eisen, parenterale Darreichungsformen: Eisen(III)-hydroxid-Saccharose-Komplex; Eisen(III)-hydroxid-Dextran-Komplex; Eisen(III)-Natrium-D-gluconat-Komplex; Eisenderisomaltose; ATC-Code: B03AC02, B03AC06, B03AC07, B03AC08 (ADV); B03AC (WHO); Epoetin alfa und Epoetin zeta; ATC-Code: B03XA01; Etanercept; ATC-Code: L04AB01; Filgrastim; ATC-Code: L03AA02; Glibenclamid; ATC-Code: A10BB01; Lercanidipin; ATC-Code: C08CA13; Mepolizumab; ATC-Code: R03DX09; Pegfilgrastim; ATC-Code: L03AA13; Propranolol; Lösung zum Einnehmen; ATC-Code: C07AA05; Risperidon; Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension; 75 mg und 100 mg; ATC-Code: N05AX08; Stiripentol; ATC-Code: N03AX17; Tafluprost; ATC-Code: S01EE05; Tafluprost und Timolol; ATC-Code: S01ED70 (ADV), S01ED51 (WHO); Teriparatid; ATC-Code: H05AA02; Tofacitinib; ATC-Code: L04AF01; Trientin; Filmtabletten 150 mg; Hartkapseln 100 mg; ATC-Code: A16AX12; Vitamine, Kombinationen; Cernevit(R), Frekavit(R), Natrovit(R), Soluvit(R), Viant(R), Vitalipid(R); ATC-Code: B05XC30 (ADV), B05XC (WHO); Tocilizumab; ATC-Code: L04AC07; Ivermectin; Creme; ATC-Code: D11AX22; Propranolol; Filmtabletten, Tabletten; ATC-Code: C07AA05

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in German.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

More from this buyer

Full buyer profile

15 open tenders right now

Who usually wins this buyer's contracts in this sector

Based on 18 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 17 comparable contracts this buyer awarded in this sector over the last 4 years.

Lower quartile
€1
Median award
€1
Upper quartile
€1

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now May 5, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.
  2. Act now
    • Submission deadline: Moved 1 day EARLIER: now May 5, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.
  3. Act now
    • Submission deadline: Moved 1 day EARLIER: now May 5, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,063,485
9,570 open across Europe right now
Buyer track record on Aperlena
70 notices tracked · 29 awarded
€462,107,931 in awarded contracts

Never miss a tender like this

58 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

585 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language